Efecto del olmesartán (ARA-II) en pacientes con enfermedad renal crónica severa en situación de prediálisis, hemodiálisis y diálisis peritoneal

Treatment with OLM in patients with ad-vanced CKD in preD, PD and HD is effective for BP control and is very well tolerated. Despite severe renal disease, OLM significantly reduces proteinuria, with no deleterious effects on renal function or anemia. The promising effects onparameters of inflammation require confirmation.